GHS2025 reflects Hevolution Foundation’s commitment to not only accelerating geroscience research but also fostering ethical accountability in its implementation. Ahead of his GHS2025 panel, we spoke with Dr Caplan about the ethical challenges in healthspan research, including equitable access, transparency in gene therapy, the societal impact of weight-loss drugs and the need for rigorous safety measures in longevity interventions. https://longevity.technology/news/balancing-ethics-and-innovation-in-healthspan-research/